Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

271 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Dapagliflozin: a review on efficacy, clinical effectiveness and safety.
Paisley AN, Yadav R, Younis N, Rao-Balakrishna P, Soran H. Paisley AN, et al. Among authors: younis n. Expert Opin Investig Drugs. 2013 Jan;22(1):131-40. doi: 10.1517/13543784.2013.740009. Epub 2012 Nov 6. Expert Opin Investig Drugs. 2013. PMID: 23127205 Review.
Effect of Extended-Release Niacin on High-Density Lipoprotein (HDL) Functionality, Lipoprotein Metabolism, and Mediators of Vascular Inflammation in Statin-Treated Patients.
Yadav R, Liu Y, Kwok S, Hama S, France M, Eatough R, Pemberton P, Schofield J, Siahmansur TJ, Malik R, Ammori BA, Issa B, Younis N, Donn R, Stevens A, Durrington P, Soran H. Yadav R, et al. Among authors: younis n. J Am Heart Assoc. 2015 Sep 15;4(9):e001508. doi: 10.1161/JAHA.114.001508. J Am Heart Assoc. 2015. PMID: 26374297 Free PMC article. Clinical Trial.
Vildagliptin in clinical practice: a review of literature.
Banerjee M, Younis N, Soran H. Banerjee M, et al. Among authors: younis n. Expert Opin Pharmacother. 2009 Nov;10(16):2745-57. doi: 10.1517/14656560903302265. Expert Opin Pharmacother. 2009. PMID: 19874253 Review.
A comparison of the effects of low- and high-dose atorvastatin on lipoprotein metabolism and inflammatory cytokines in type 2 diabetes: Results from the Protection Against Nephropathy in Diabetes with Atorvastatin (PANDA) randomized trial.
Soran H, Liu Y, Adam S, Siahmansur T, Ho JH, Schofield JD, Kwok S, Gittins M, France M, Younis N, Gibson JM, Durrington PN, Rutter MK. Soran H, et al. Among authors: younis n. J Clin Lipidol. 2018 Jan-Feb;12(1):44-55. doi: 10.1016/j.jacl.2017.10.011. Epub 2017 Nov 13. J Clin Lipidol. 2018. PMID: 29246729 Clinical Trial.
271 results